Cargando…
A Case of Methimazole-Induced Acute Pancreatitis With an HLA Allele Causing Antithyroid Drug-Induced Agranulocytosis
Among the side effects of methimazole (MMI) for the treatment of Graves’ disease, MMI-induced acute pancreatitis (MIP) is a rare adverse reaction, with only 7 cases being reported to date. However, 2 large-scale population-based studies recently revealed that the risk of MIP was significantly higher...
Autores principales: | Yoshimura, Yusuke, Tatsushima, Keita, Goshima, Yukiko, Hoshino, Yoshitomo, Nakashima, Saki, Inaba, Tatsuro, Ikeda, Sara, Hattori, Daisuke, Koyama, Rikako, Imamura, Tsunao, Takeshita, Akira, Takeuchi, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989154/ https://www.ncbi.nlm.nih.gov/pubmed/35402762 http://dx.doi.org/10.1210/jendso/bvac038 |
Ejemplares similares
-
SAT-600 Relapse of Agranulocytosis after Recovery of Methimazole-Induced Agranulocytosis
por: Choi, Dughyun, et al.
Publicado: (2019) -
Antithyroid Drug-Induced Agranulocytosis: A Case Report
por: MacKay, Micaela, et al.
Publicado: (2023) -
Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors
por: Khine, Aye, et al.
Publicado: (2021) -
Agranulocytosis with tonsillitis associated with methimazole therapy
por: Zambrana, Jorge T., et al.
Publicado: (2015) -
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
por: Vicente, Nuno, et al.
Publicado: (2017)